BULLFROG AI HOLDINGS, INC. Shareholders' Equity
BULLFROG AI HOLDINGS, INC. (BFRG) had Shareholders' Equity of $6.99 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $6.99M.
- 2026-04-01: Stockholders' Equity Attributable to Parent $2.50M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $4.89M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $2.14M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $6.99M 10-Q · filed 2026-08-14 |
| 2026-04-01 | $2.50M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $4.89M 10-Q · filed 2026-08-14 |
| 2025-12-31 | $2.14M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $1.94M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.19M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $3.25M 10-Q · filed 2026-08-14 |
| 2024-12-31 | $4.96M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $3.82M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $5.39M 10-Q · filed 2025-11-14 |
| 2024-03-31 | $6.80M 10-Q · filed 2025-11-14 |
| 2023-12-31 | $2.59M 10-K · filed 2026-03-19 |
| 2023-09-30 | $3.77M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $4.90M 10-Q · filed 2024-11-08 |
| 2023-03-31 | $4.62M 10-Q · filed 2024-11-08 |
| 2022-12-31 | -$3.06M 10-K · filed 2025-03-14 |
| 2022-09-30 | -$2.41M 10-Q · filed 2023-11-14 |
| 2022-06-30 | -$1.89M 10-Q · filed 2023-11-14 |
| 2022-03-31 | -$1.55M 10-Q · filed 2023-11-14 |
| 2021-12-31 | -$1.01M 10-K · filed 2024-03-29 |
| 2020-12-31 | -$540.52K 10-K · filed 2023-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |